Details for Patent: 9,526,835

Which drugs does patent 9,526,835 protect, and when does it expire?

Patent 9,526,835 protects REZZAYO and is included in one NDA.

This patent has fifty-two patent family members in twenty-three countries.

Summary for Patent: 9,526,835

Title:	Dosing regimens for echinocandin class compounds
Abstract:	The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds.
Inventor(s):	Balasingam Radhakrishnan, Kenneth Duke James, JR., Anuradha Vaidya, Karen Polowy
Assignee:	NAPP PHARMACEUTICAL GROUP Ltd , Seachaid Pharmaceuticals LLC
Application Number:	US14/386,266
Patent Claim Types: see list of patent claims	Use; Composition; Formulation;

Drugs Protected by US Patent 9,526,835

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Mundipharma	REZZAYO	rezafungin acetate	POWDER;INTRAVENOUS	217417-001	Mar 22, 2023		RX	Yes	Yes	9,526,835		Y	Y		TREATMENT OF CANDIDEMIA AND INVASIVE CANDIDIASIS WITH REZAFUNGIN BY INTRAVENOUS ADMINISTRATION

International Family Members for US Patent 9,526,835

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2013235512
Australia	2017201758
Australia	2019201072